Cidara Therapeutics (CDTX)
(Real Time Quote from BATS)
$13.05 USD
+0.63 (5.07%)
Updated May 31, 2024 12:16 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Brokerage Reports
Cidara Therapeutics, Inc. [CDTX]
Reports for Purchase
Showing records 141 - 145 ( 145 total )
Company: Cidara Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Q2:EPS; Second-Generation Cloudbreak Strategy Announced, Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Cidara Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE: 2015 Wedbush PacGrow Healthcare Conference Day 2
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Cidara Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
CD101 Enters the Clinic, Quick Data Readout Expected, Reiterate Outperform
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Cidara Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Q1:EPS; CD101 Granted Qualified Infectious Disease Product (QIDP) With Fast Track Status
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Cidara Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Initiating Coverage with an OUTPERFORM Rating and $22 Price Target: Better Living through New Antifungals
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D